Sirio Pharma (300791) — Free Cash Flow Generation Index
Sirio Pharma (300791) has a Free Cash Flow Generation Index of 0.41x as of June 2023. Free cash flow of CN¥41.96 Million represents 0% of operating cash flow (CN¥101.61 Million). Explore 300791 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sirio Pharma Free Cash Flow Generation Index (2017–2024)
Historical FCF Generation Index trend for Sirio Pharma across 8 annual periods. For the full cash flow conversion analysis, see 300791 cash flow conversion.
Annual Free Cash Flow Generation for Sirio Pharma (2017–2024)
Year-by-year Free Cash Flow Generation Index for Sirio Pharma. Check Sirio Pharma cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.27x | CN¥154.84 Million | CN¥566.97 Million | CN¥412.13 Million | ▲ +260.7% |
| 2023 | -0.17x | CN¥-65.62 Million | CN¥386.08 Million | CN¥451.70 Million | ▼ -150.0% |
| 2022 | 0.34x | CN¥151.17 Million | CN¥444.86 Million | CN¥293.69 Million | ▲ +163.3% |
| 2021 | -0.54x | CN¥-183.31 Million | CN¥341.38 Million | CN¥524.68 Million | ▼ -278.0% |
| 2020 | 0.30x | CN¥96.43 Million | CN¥319.57 Million | CN¥223.14 Million | ▲ +8.0% |
| 2019 | 0.28x | CN¥64.71 Million | CN¥231.60 Million | CN¥166.90 Million | ▲ +191.7% |
| 2018 | -0.30x | CN¥-55.87 Million | CN¥183.46 Million | CN¥239.32 Million | ▲ +86.4% |
| 2017 | -2.24x | CN¥-110.47 Million | CN¥49.35 Million | CN¥159.82 Million | — |